CAS 111321-02-9
:Erythromycin oxime
- Unii-10W452Cmtz
- Erythromycin, 9-oxime
- Erythromycin A Oxime
- (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-oxime (non-preferred name)
Erythromycin Oxime
CAS:Lactones, nesoiFormula:C37H68N2O13Color and Shape:White Off-White SolidMolecular weight:748.47214Roxithromycin EP Impurity C (Erythromycin A 9-Oxime (E-Isomer))
CAS:Formula:C37H68N2O13Color and Shape:White To Off-White SolidMolecular weight:748.959(E)-Erythromycin A oxime
CAS:(9E)-Erythromycin A oxime is a metabolite of the semisynthetic antibiotic roxithromycin .Formula:C37H68N2O13Color and Shape:SolidMolecular weight:748.94(9E)-Erythromycin A Oxime
CAS:Controlled ProductApplications (9E)-Erythromycin A Oxime is a metabolite of Roxithromycin (R700850) in humans. It has anti-Helicobacter pylori activity
References Nam, G. et al.: Bioorg. Med. Chem. Lett., 16, 569 (2006); Zhong, D. et al.: Drug Metab. Dispos., 28, 552 (2000); Yamazaki, H. et al.: Drug. Metab. Dispos., 26, 1053 (1998)Formula:C37H68N2O13Color and Shape:NeatMolecular weight:748.94Roxithromycin EP Impurity C
CAS:Roxithromycin EP Impurity C is a byproduct of the synthesis of erythromycin. It has been shown to have anti-inflammatory activity in liver cells, and has been used as a model for studying the mechanism of action of erythromycin. The reaction solution contains inorganic acid and nitrogen atoms. Roxithromycin EP Impurity C reacts with erythromycin to form an intermediate that then undergoes a series of reactions, including hydroxylation, oxidation, and decarboxylation. The purified product is made up of carbonyl groups and transcriptional regulation. This impurity can also be found in cell nuclei.
Formula:C37H68N2O13Purity:Min. 95%Molecular weight:748.94 g/mol








